IMMUNITYBIO, INC. (IBRX) Stock buybacks 2016–2021
IMMUNITYBIO, INC. (IBRX) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$0FY2021 · since FY2016: $15.8M → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | $0 | — |
| FY2020 | $0 | -100.0% |
| FY2019 | $2.5M | +996.9% |
| FY2018 | $228,000 | -98.5% |
| FY2017 | $15.2M | -3.9% |
| FY2016 | $15.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IBRX financial trends
IBRX RevenueIBRX Net incomeIBRX Net marginIBRX Gross profitIBRX Gross marginIBRX Operating incomeIBRX Operating marginIBRX Operating cash flowIBRX Free cash flowIBRX Capital expendituresIBRX Return on equityIBRX Dividends paidIBRX Total assetsIBRX Total liabilitiesIBRX Shareholders’ equityIBRX overview →